Form 8-K - Current report:
SEC Accession No. 0001104659-05-024770
Filing Date
2005-05-20
Accepted
2005-05-20 16:22:25
Documents
4
Period of Report
2005-05-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a05-9676_18k.htm 8-K 35212
2 EX-10.01 a05-9676_1ex10d01.htm EX-10.01 34311
3 EX-99.1 a05-9676_1ex99d1.htm EX-99.1 7052
4 GRAPHIC g96761mmimage002.jpg GRAPHIC 10862
  Complete submission text file 0001104659-05-024770.txt   93337
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
Type: 8-K | Act: 34 | File No.: 001-12493 | Film No.: 05848514
SIC: 2836 Biological Products, (No Diagnostic Substances)